Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China (Q33590853)

28 July 2017

title

Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China (English)

1 reference

28 July 2017

main subject

hepatocellular carcinoma

1 reference

Ming Shi

1

0 references

author name string

Ji-An Chen

2

1 reference

28 July 2017

Xiao-Jun Lin

3

1 reference

28 July 2017

Rong-Ping Guo

4

1 reference

28 July 2017

Yun-Fei Yuan

5

1 reference

28 July 2017

Min-Shan Chen

6

1 reference

28 July 2017

Ya-Qi Zhang

7

1 reference

28 July 2017

Jin-Qing Li

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

World Journal of Gastroenterology

28 July 2017

published in

1 reference

28 July 2017

volume

16

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

264-269

1 reference

Prognostic analysis of pulmonary metastases from hepatocellular carcinoma

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

The global health burden of infection-associated cancers in the year 2002

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Management of hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Global cancer statistics, 2002

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

21 June 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Natural history of untreated nonsurgical hepatocellular carcinoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806567

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

31 October 2018

1 reference

12 December 2020

Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors

1 reference

12 December 2020

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study

1 reference

12 December 2020

Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management

1 reference

12 December 2020

A simple prognostic scoring system for patients with unresectable hepatocellular carcinoma treated by chemo-embolization

1 reference

12 December 2020

Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre

1 reference

12 December 2020

Predicting survival in patients with liver cancer considered for transarterial chemoembolization

1 reference

12 December 2020

Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V16.I2.264

1 reference

release_navoouomwbbyxe3hao2mg4jnsa

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/navoouomwbbyxe3hao2mg4jnsa

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2806567

1 reference

28 July 2017

1 reference